An ultrasensitive biosensor made from the wonder material graphene has been used to detect molecules that indicate an increased risk of developing cancer.
The biosensor has been shown to be more than five times more sensitive than bioassay tests currently in use, and was able to provide results in a matter of minutes, opening up the possibility of a rapid, point-of-care diagnostic tool for patients. The biosensor has been presented today, 19 September, in IOP Publishing’s journal 2D Materials.
To develop a viable biosensor, the researchers, from the University of Swansea, had to create patterned graphene devices using a large substrate area, which was not possible using the traditional exfoliation technique where layers of graphene are stripped from graphite.
Instead, they grew graphene onto a silicon carbide substrate under extremely high temperatures and low pressure to form the basis of the biosensor. The researchers then patterned graphene devices, using semiconductor processing techniques, before attaching a number of bioreceptor molecules to the graphene devices. These receptors were able to bind to, or target, a specific molecule present in blood, saliva or urine.
The Latest on: Biosensor
via Google News
The Latest on: Biosensor
- PhysIQ Recognized as a 2021 Hottest Health Tech Companyon January 15, 2021 at 12:57 am
The Observer names physIQ as one of the hottest tech companies in the US second straight year for outstanding work amid the global COVID-19 pandemic. (Photo: Business Wire) In early 2020, physIQ ...
- Texas A&M students create a rapid COVID-19 test prototype using biosensor technologyon January 14, 2021 at 10:04 pm
News Highlights: Texas A&M students create a rapid COVID-19 test prototype using biosensor technology COLLEGE STATION, Texas (KBTX) - Four Texas A&M ...
- Texas A&M students create rapid COVID-19 test prototype using biosensor technologyon January 14, 2021 at 8:59 pm
COLLEGE STATION, Texas (KBTX) - Four Texas A&M biomedical engineering students teamed up to create a prototype for a rapid COVID-19 test that uses a biosensor. At the outset of the pandemic ...
- One step closer to an at-home, rapid COVID-19 teston January 14, 2021 at 9:48 am
The FINANCIAL -- The lab of César de la Fuente is working on a paper-based biosensor that could provide results in minutes. Clinical trials began Jan. 5. The lab of Penn’s César de la Fuente ...
- PhysIQ Recognized as a 2021 Hottest Health Tech Companyon January 14, 2021 at 6:14 am
The company uses near real time biosensor data combined with platform powered by FDA-cleared AI based analytics and transforms it into personalized patient insights for healthcare providers and ...
- Improved understanding and treatment of inflammatory diseaseson January 13, 2021 at 3:57 am
Over the next four years, the international research project SciFiMed aims to develop a biosensor to help better characterise inflammatory reactions in the body. This visionary project ...
- Glucose Biosensor Market Research, Report, In-depth Insight, Industry Forecast to 2025 Key playerson January 5, 2021 at 10:00 pm
The Glucose Biosensor Market is expected to exceed more than US$ 30.5 Billion by 2024 at a CAGR of 10.29% in the ...
via Bing News